Heron Therapeutics, Inc.
LSE: 0J4V.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Craig Alexander Collard
- Employees
- 122
- Headquarters
- Cary, United States
- IPO year
- 2018
- Market cap
- $205.9M
- Website
- https://www.herontx.com
Loading 0J4V…
Loading profile data…Frequently asked questions about 0J4V
What does Heron Therapeutics, Inc. (0J4V.L) do?
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
Where does 0J4V.L trade?
Heron Therapeutics, Inc. (0J4V.L) trades on the London Stock Exchange.
What sector is 0J4V.L in?
Heron Therapeutics, Inc. (0J4V.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Heron Therapeutics, Inc.?
Craig Alexander Collard is the chief executive officer of Heron Therapeutics, Inc. (0J4V.L).
Where is Heron Therapeutics, Inc. headquartered?
Heron Therapeutics, Inc. is headquartered in United States.
Does 0J4V.L pay a dividend?
Heron Therapeutics, Inc. (0J4V.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0J4V.L go public?
Heron Therapeutics, Inc. (0J4V.L) completed its initial public offering in 2018.